AMYRIS INC's ticker is AMRS and the CUSIP is 03236M200. A total of 87 filers reported holding AMYRIS INC in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $464,000 | +22.1% | 75,189 | -42.2% | 0.01% | +9.1% |
Q3 2020 | $380,000 | +120.9% | 130,189 | +223.9% | 0.01% | +83.3% |
Q2 2020 | $172,000 | -58.3% | 40,189 | -75.0% | 0.01% | -64.7% |
Q1 2020 | $412,000 | -17.1% | 160,756 | 0.0% | 0.02% | -10.5% |
Q4 2019 | $497,000 | +72.6% | 160,756 | +164.6% | 0.02% | +58.3% |
Q3 2019 | $288,000 | -7.7% | 60,756 | -59.5% | 0.01% | -7.7% |
Q1 2019 | $312,000 | -68.5% | 150,000 | -49.3% | 0.01% | -68.3% |
Q4 2018 | $989,000 | +140.0% | 296,000 | +469.2% | 0.04% | +192.9% |
Q3 2018 | $412,000 | -38.0% | 52,000 | -50.0% | 0.01% | -41.7% |
Q2 2018 | $665,000 | 0.0% | 104,000 | 0.0% | 0.02% | 0.0% |
Q1 2018 | $665,000 | -14.7% | 104,000 | -50.0% | 0.02% | +71.4% |
Q4 2017 | $780,000 | +275.0% | 208,000 | +220.0% | 0.01% | +100.0% |
Q3 2017 | $208,000 | +28.4% | 65,000 | +30.0% | 0.01% | +16.7% |
Q2 2017 | $162,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,217,216 | $36,295,000 | 13.66% |
Vivo Capital, LLC | 11,639,929 | $190,546,000 | 8.25% |
One Fin Capital Management LP | 969,274 | $15,867,000 | 6.26% |
PINNACLE ASSOCIATES LTD | 4,660,308 | $76,289,000 | 1.38% |
Vantis Investment Advisers L.P. | 66,000 | $1,080,000 | 1.36% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 518,262 | $8,484,000 | 1.30% |
Nicholas Investment Partners, LP | 1,248,778 | $20,442,000 | 1.28% |
Casdin Capital, LLC | 3,000,000 | $49,110,000 | 1.25% |
FARALLON CAPITAL MANAGEMENT LLC | 13,110,000 | $214,611,000 | 0.88% |
Bill & Melinda Gates Foundation | 292,398 | $4,800,000 | 0.74% |